HuGE Literature Finder
Records
1
-
30
| [Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
| Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood advances 2020 May 4 (9): 1942-1949. Gardin Claude, Pautas Cécile, Fournier Elise, Itzykson Raphaël, Lemasle Emilie, Bourhis Jean-Henri, Adès Lionel, Marolleau Jean-Pierre, Malfuson Jean-Valère, Gastaud Lauris, Raffoux Emmanuel, Lambert Juliette, Braun Thorsten, Thomas Xavier, Chantepie Sylvain, Cluzeau Thomas, de Botton Stéphane, Berthon Céline, Boissel Nicolas, Duployez Nicolas, Terré Christine, Peffault de Latour Régis, Michallet Mauricette, Celli-Lebras Karine, Preudhomme Claude, Dombret Her |
| Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes. Cancer science 2019 Dec . Jiang Lingxu, Luo Yingwan, Zhu Shuanghong, Wang Lu, Ma Liya, Zhang Hua, Shen Chuying, Yang Wenli, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis.
Blood advances 2019 Nov 3 (22): 3579-3589. McGraw Kathy L, Cheng Chia-Ho, Chen Y Ann, Hou Hsin-An, Nilsson Björn, Genovese Giulio, Cluzeau Thomas, Pellagatti Andrea, Przychodzen Bartlomiej P, Mallo Mar, Arenillas Leonor, Mohamedali Azim, Adès Lionel, Sallman David A, Padron Eric, Sokol Lubomir, Moreilhon Chimene, Raynaud Sophie, Tien Hwei-Fang, Boultwood Jacqueline, Ebert Benjamin L, Sole Francesc, Fenaux Pierre, Mufti Ghulam J, Maciejewski Jaroslaw P, Kanetsky Peter A, List Alan |
| Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. Blood advances 2019 Oct 3 (20): 3111-3122. Berger Gerbrig, Gerritsen Mylene, Yi Guoqiang, Koorenhof-Scheele Theresia N, Kroeze Leonie I, Stevens-Kroef Marian, Yoshida Kenichi, Shiraishi Yuichi, van den Berg Eva, Schepers Hein, Huls Geert, Mulder André B, Ogawa Seishi, Martens Joost H A, Jansen Joop H, Vellenga E |
| [Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Sep 36 (9): 857-861. Qin Wei, Chen Meiyu, Cai Xiaohui, Chao Hongying, Liu Jie, Jiang Naike, Zhou Min, Lu Xuzhang, Chen Suning, Zhang Ri, He Chuan, Wang Qi |
| Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes. Leukemia 2019 Feb . Follo Matilde Y, Pellagatti Andrea, Armstrong Richard N, Ratti Stefano, Mongiorgi Sara, De Fanti Sara, Bochicchio Maria Teresa, Russo Domenico, Gobbi Marco, Miglino Maurizio, Parisi Sarah, Martinelli Giovanni, Cavo Michele, Luiselli Donata, McCubrey James A, Suh Pann-Ghill, Manzoli Lucia, Boultwood Jacqueline, Finelli Carlo, Cocco Luc |
| TET2 rs2454206, TET2 rs12498609 and ASXL1 rs3746609 single nucleotide polymorphisms in patients with myelodysplastic syndromes. Blood cells, molecules & diseases 2019 Feb 74 44-50. Hu Jinjun, Xu Jing, Tian Tingting, Xie Juan, Fan Lifang, Zhu Guiyang, Xia Ting, Chen Xi, Tan Yanhong, Chen Xiuhua, Ren Fanggang, Zhang Yaofang, Wang Hongwei, Xu Zhifa |
| Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts. Leukemia research 2018 Aug 71 60-62. Mangaonkar Abhishek A, Gangat Naseema, Al-Kali Aref, Elliott Michelle A, Begna Kebede H, Hanson Curtis A, Ketterling Rhett P, Wolanskyj-Spinner Alexandra P, Hogan William J, Litzow Mark R, Patnaik Mrinal |
| ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics. Leukemia & lymphoma 2018 Feb 1-8. Kakosaiou Katerina, Panitsas Fotios, Daraki Aggeliki, Pagoni Maria, Apostolou Paraskevi, Ioannidou Agapi, Vlachadami Ioanna, Marinakis Theodoros, Giatra Chara, Vasilatou Diamantina, Sambani Constantina, Pappa Vassiliki, Manola Kalliopi |
| Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model. American journal of hematology 2018 Feb . Gangat Naseema, Mudireddy Mythri, Lasho Terra L, Finke Christy M, Nicolosi Maura, Szuber Natasha, Patnaik Mrinal M, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
| Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R. American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
| Clinical significance of somatic mutation in unexplained blood cytopenia. Blood 2017 Apr . Malcovati Luca, Gallì Anna, Travaglino Erica, Ambaglio Ilaria, Rizzo Ettore, Molteni Elisabetta, Elena Chiara, Ferretti Virginia Valeria, Catricalà Silvia, Bono Elisa, Todisco Gabriele, Bianchessi Antonio, Rumi Elisa, Zibellini Silvia, Pietra Daniela, Boveri Emanuela, Camaschella Clara, Toniolo Daniela, Papaemmanuil Elli, Ogawa Seishi, Cazzola Mar |
| Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia. American journal of hematology 2017 Mar . Patnaik Mrinal M, Barraco Daniela, Lasho Terra L, Finke Christy M, Reichard Kaaren, Hoversten Katherine P, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
| Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Sep . Della Porta Matteo G, Gallì Anna, Bacigalupo Andrea, Zibellini Silvia, Bernardi Massimo, Rizzo Ettore, Allione Bernardino, van Lint Maria Teresa, Pioltelli Pietro, Marenco Paola, Bosi Alberto, Voso Maria Teresa, Sica Simona, Cuzzola Mariella, Angelucci Emanuele, Rossi Marianna, Ubezio Marta, Malovini Alberto, Limongelli Ivan, Ferretti Virginia V, Spinelli Orietta, Tresoldi Cristina, Pozzi Sarah, Luchetti Silvia, Pezzetti Laura, Catricalà Silvia, Milanesi Chiara, Riva Alberto, Bruno Benedetto, Ciceri Fabio, Bonifazi Francesca, Bellazzi Riccardo, Papaemmanuil Elli, Santoro Armando, Alessandrino Emilio P, Rambaldi Alessandro, Cazzola Mar |
| Clonal hematopoiesis in acquired aplastic anemia. Blood 2016 Apr . Ogawa Seis |
| Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing. American journal of hematology 2016 Feb . Patnaik Mrinal M, Lasho Terra L, Finke Christy M, Hanson Curtis A, King Rebecca L, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
| Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes. Nature communications 2015 6 5901. Gerstung Moritz, Pellagatti Andrea, Malcovati Luca, Giagounidis Aristoteles, Porta Matteo G Della, Jädersten Martin, Dolatshad Hamid, Verma Amit, Cross Nicholas C P, Vyas Paresh, Killick Sally, Hellström-Lindberg Eva, Cazzola Mario, Papaemmanuil Elli, Campbell Peter J, Boultwood Jacqueli |
| IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. American journal of hematology 2014 Feb 89 (2): 137-44. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Liu Chieh-Yu, Chen Chien-Yuan, Lai Yan-Jun, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 2014 Feb 28 (2): 241-7. Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler H P, Klein H-U, Dugas M, Aburatani H, Kohlmann A, Miyano S, Haferlach C, Kern W, Ogawa |
| Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia 2014 Jan 28 (1): 78-87. Traina F, Visconte V, Elson P, Tabarroki A, Jankowska A M, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe C L, Sekeres M A, Advani A S, Kalaycio M, Copelan E A, Saunthararajah Y, Olalla Saad S T, Maciejewski J P, Tiu R |
| Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes. Haematologica 2013 Dec 98 (12): 1856-64. Fernandez-Mercado Marta, Burns Adam, Pellagatti Andrea, Giagounidis Aristoteles, Germing Ulrich, Agirre Xabier, Prosper Felipe, Aul Carlo, Killick Sally, Wainscoat James S, Schuh Anna, Boultwood Jacqueli |
| SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia 2013 Sep 27 (9): 1852-60. Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger |
| TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes. Leukemia research 2013 Mar 37 (3): 305-11. Wang Jieyu, Ai Xiaofei, Gale Robert Peter, Xu Zefeng, Qin Tiejun, Fang Liwei, Zhang Hongli, Pan Lijuan, Hu Naibo, Zhang Yue, Xiao Zhiji |
| ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome. Leukemia 2013 Jan 27 (1): 82-91. Schnittger S, Eder C, Jeromin S, Alpermann T, Fasan A, Grossmann V, Kohlmann A, Illig T, Klopp N, Wichmann H-E, Kreuzer K-A, Schmid C, Staib P, Peceny R, Schmitz N, Kern W, Haferlach C, Haferlach |
| Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia. Haematologica 2013 Jan . Shih AH, Chung SS, Dolezal EK, Zhang SJ, Abdel-Wahab OI, Park CY, Nimer SD, Levine RL, Klimek VM |
| Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Sep 30 (27): 3376-82. Bejar Rafael, Stevenson Kristen E, Caughey Bennett A, Abdel-Wahab Omar, Steensma David P, Galili Naomi, Raza Azra, Kantarjian Hagop, Levine Ross L, Neuberg Donna, Garcia-Manero Guillermo, Ebert Benjamin |
| Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012 Apr 119 (15): 3578-84. Thol Felicitas, Kade Sofia, Schlarmann Carola, Löffeld Patrick, Morgan Michael, Krauter Jürgen, Wlodarski Marcin W, Kölking Britta, Wichmann Martin, Görlich Kerstin, Göhring Gudrun, Bug Gesine, Ottmann Oliver, Niemeyer Charlotte M, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
| Clinical effect of point mutations in myelodysplastic syndromes. The New England journal of medicine 2011 Jun 364 (26): 2496-506. Bejar Rafael, Stevenson Kristen, Abdel-Wahab Omar, Galili Naomi, Nilsson Björn, Garcia-Manero Guillermo, Kantarjian Hagop, Raza Azra, Levine Ross L, Neuberg Donna, Ebert Benjamin |
| Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Jun 29 (18): 2499-506. Thol Felicitas, Friesen Inna, Damm Frederik, Yun Haiyang, Weissinger Eva M, Krauter Jürgen, Wagner Katharina, Chaturvedi Anuhar, Sharma Amit, Wichmann Martin, Göhring Gudrun, Schumann Christiane, Bug Gesine, Ottmann Oliver, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Heuser Michael, Ganser Arno |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 27, 2022
- Content source: